Samuel C. Blackman

Dabrafenib in patients with melanoma, untreated brain metastases, and other solid tumours: a phase 1 dose-escalation trial

Gerald S. Falchook, Georgina V. Long, Razelle Kurzrock et al. · The Lancet · 2012 · 933 citations · Full text

Medicine, Oncology, Pharmacotherapy +12

Phase I Pharmacologic and Pharmacodynamic Study of the Gamma Secretase (Notch) Inhibitor MK-0752 in Adult Patients With Advanced Solid Tumors

Ian E. Krop, Tim Demuth, Tina Guthrie et al. · Journal of Clinical Oncology · 2012 · 317 citations · Full text

Medicine, Pharmacokinetics, Pharmacology +16

The type II RAF inhibitor tovorafenib in relapsed/refractory pediatric low-grade glioma: the phase 2 FIREFLY-1 trial

Lindsay Kilburn, Dong-Anh Khuong-Quang, Jordan R. Hansford et al. · Nature Medicine · 2023 · 177 citations · Full text

Medicine, Oncology, Pharmacology +15

Postcesarean Analgesia with Both Epidural Morphine and Intravenous Patient-Controlled Analgesia

Bernard Wittels, Beth Glosten, Eveline A. M. Faure et al. · Anesthesia & Analgesia · 1997 · 75 citations

Nursing, Anesthesiology, Maternal Health +13

Dose Selection, Pharmacokinetics, and Pharmacodynamics of BRAF Inhibitor Dabrafenib (GSK2118436)

Gerald S. Falchook, Georgina V. Long, Razelle Kurzrock et al. · Clinical Cancer Research · 2014 · 65 citations

Medicine, Pharmacokinetics, Pharmacology +17